SFA Therapeutics
SFA Therapeutics is a microbiome-derived metabolites as drugs founded in 2016 by Ira Spector, Mark Feitelson and Alla Arzumanyan.
1
Funding Rounds
$4.0m
Money raised
Overview
SFA Therapeutics is a microbiome-derived metabolites as drugs founded in 2016 by Ira Spector, Mark Feitelson and Alla Arzumanyan.
-
Website:
- Business model: B2B
- Social accounts:
Industries
SFA Therapeutics is active in the following industries: